Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Process Economics of Animal Cell and Bacterial Fermentations: A Case Study Analysis of Tissue Plasminogen Activator

Bio/Technology volume 11, pages 349–357 (1993)Cite this article

Abstract

One link in the complex chain of medical economics is the cost of bringing new drugs and biologicals to the market. Advances in recombinant-DNA technology permit production of therapeutically active proteins in effectively unlimited quantities. Nevertheless, each expression system has a characteristic influence on the nature of the product produced and the process required to obtain it. In this case study we compare experiences with recombinant-tissue plasminogen activator (rtPA) produced in Chinese hamster ovary (CHO) cells and in Escherichia coli, with the aim of understanding the roles of some of the parameters that affect process economics. tPA belongs to the group of highly specific serine proteases that convert plasminogen to plasmin, which in turn degrades several protein substrates including fibrin, thus making it an effective thrombolytic agent. The treatment of acute myocardial infarction with such thrombolytic agents can result in early discharge of patients and decreased medical costs. However, there are major differences in the prices of the various available agents. The price of the FDA-licensed tPA product is $2,200 per dose or $22,000 per gram. It is believed that a significant portion of this price relates to manufacturing costs. We examine by way of case study illustration the cost breakdown for the two processes, and highlight important process, design and economic considerations that ultimately define a particular protein product.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Spalding, B.J. 1991. Downstream processing: Key to slashing production costs 100 fold. Bio/Technology 9: 229–233.

    CAS  Google Scholar 

  2. Pennica, D., Holmes, W.E., Kohr, W.J., Harkins, R.N., Vehar, G.A., Ward, C.A., Bennet, W.F., Yelverton, E., Seeburg, P.H., Heyneker, H.L., Eodal, D.R. and Collen, D. 1983. Cloning and expression of tissue type plasminogen activator in E. coli. Nature 301: 214–221.

    Article  CAS  PubMed  Google Scholar 

  3. Harris, T.J.R., Patel, T., Marston, F.A.O., Little, S., Emtage, S., Open-dakker, G., Volkaert, G., Rombauts, W., Billiau, A. and De Somer, P. 1986. Cloning of cDNA coding for human tPA and its expression in E. coli. Mol. Biol. Med. 3: 279–292.

    CAS  PubMed  Google Scholar 

  4. Thayer, A. 1991. Anti-clot drug study may hurt biotech sales. Chem. Eng. News. March 11: 6.

    Google Scholar 

  5. Bluestone, M. 1992. tPA falls short once again. Bio/Technology 10: 480.

    Google Scholar 

  6. Pohl, G., Kallstrom, M., Bergsdorf, N., Wallen, P. and Jornvall, H. 1984. Tissue plasminogen activator: peptide analyses confirm an indirectly derived amino acid sequence, identify the active site serine residue, establish glycosylation sites and localize variant differences. Biochemistry 23: 3701–3707.

    Article  CAS  PubMed  Google Scholar 

  7. Collen, D., Stassen, J.M., Marafino, B.J. Jr., Builder, S., De Cock, F., Ogez, I., Tajiri, D., Pennica, D., Bennett, V.F., Salwa, J. and Hoyng, C.F. 1984. Biological properties of human tissue type plasminogen activator obtained by expression of recombinant DNA in animal cells. J. Pharmacol. Exp. Therap. 231: 146–152.

    CAS  Google Scholar 

  8. Milstone, H. 1941. J. Immunol. 42: 109–116.

    CAS  Google Scholar 

  9. Hansen, L., Blue, Y., Barone, K., Collen, D. and Larsen, G.R. 1988. Functional effects of asparagine-linked oligosaccharide on natural and variant human tissue-type plasminogen activator. J. Biol. Chem. 263: 15713–15719.

    CAS  PubMed  Google Scholar 

  10. Klausner, A. 1986. Researchers probe second-generation tPA. Bio/Technology 4: 706–711.

    Google Scholar 

  11. Genentech, Inc. 1988. Third quarter report. September 30.

  12. Genentech, Inc. 1990. Activase® Info-Line. November.

  13. International reference standard tPA preparation (83/157). World Health Organization.

  14. Dodd, I., Jalapour, S., Southwick, W., Newsome, P., Browne, M.J. and Robinson, J.H. 1986. Large scale, rapid purification of recombinant tissue-type plasminogen activator. FEBS Lett. 209 13–17

    Article  CAS  PubMed  Google Scholar 

  15. Schimke, R. 1978. Gene amplification in animal cells. Cell 37: 705–713.

    Article  Google Scholar 

  16. Stark, G. and Wahl, G. 1984. Gene amplification. Ann. Rev. Biochem. 53: 447–491.

    Article  CAS  PubMed  Google Scholar 

  17. Wallen, P., Pohl, G., Bergsdorf, N., Ranby, M., Ny, T. and Jornall, H. 1983. Purification and characterization of a melanoma cell plasminogen activator. Bur. J. Biochem. 132: 681–686.

    CAS  Google Scholar 

  18. Brouty-Boye, C.G., Maman, M., Marian, J. and Choay, P. 1984. Biosynthesis of human tissue-type plasminogen activator by normal cells. Bio/Technology 2: 1058–1062.

    Article  Google Scholar 

  19. Sarmientos, P., Duchesne, M., Denefte, P., Boiziau, J., Fromage, N., Delporte, N., Parker, F., Lelievre, Y., Mayaux, J.F. and Cartwright, T. 1989. Synthesis and purification of active human tissue plasminogen activator from E. coli. Bio/Technology 7: 495–501.

    CAS  Google Scholar 

  20. Latta, M., Knapp, M., Sarmientos, P., Brefort, G., Becquart, J., Guerrier, L., Jung, G. and Mayaux, J.F. 1987. Synthesis and purification of native human serum albumin from E. coli. Bio/Technology 5: 1309–1314.

    CAS  Google Scholar 

  21. Graff, R., Lang, K., Wrba, A. and Schmid, F.X. 1986. Folding mechanisms of porcine ribonuclease. J. Mol. Biol. 191: 281–293.

    Article  Google Scholar 

  22. Points to consider in the production and testing of new drugs and biologicals produced by recombinant DNA technology. 1985. US Office of Biologies Research and Review, FDA, Washington, DC.

  23. Datar, R. 1986. A comparative study of primary separation steps in fermentation. Ph.D. Thesis, Royal Institute of Technology, Stockholm, Sweden.

  24. Datar, R. and Rosen, C.-G. 1990. Downstream process economics, p. 741–793. In: Separation Processes in Biotechnology, Asenjo, J.A. (Ed.). Marcel Dekker,Inc., New York.

    Google Scholar 

  25. Ulrich, G.D. 1984. A Guide to Chemical Engineering Process Design and Economics. John Wiley & Sons, Inc., New York.

    Google Scholar 

  26. White, H.D., Rivers, J.T., Maslowski, A.H., Ormiston, J.A., Takayama, M., Hart, H.H., Sharpe, D.N., Whitelock, R.M.L. and Norris, R.M., 1989. Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction. N. Engl. J. Med. 320: 817–821.

    Article  CAS  PubMed  Google Scholar 

  27. Grunfeld, H., Patel, A., Shatzman, A. and Nishikawa, A.H. 1992. Effector-assisted refolding of recombinant tissue-plasminogen activator produced in Escherickia coli. Appl. Biochem. Biotechnol. 33: 117–138.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Rajiv V. Datar: Corresponding author.

Authors and Affiliations

  1. Pall Corporation, 30 Sea Cliff Ave., Glen Cove, NY, 11542

    Rajiv V. Datar

  2. TCS Biologicals, Ltd. (formerly Tissue Culture Services). Botolph Claydon, Buckingham, MK18 2LR, UK

    Terence Cartwright

  3. Abitec AB, Villavagen 36, S-640 50, Bjornlunda, Sweden

    Carl-Gustaf Rosen

Authors
  1. Rajiv V. Datar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Terence Cartwright
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carl-Gustaf Rosen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Datar, R., Cartwright, T. & Rosen, CG. Process Economics of Animal Cell and Bacterial Fermentations: A Case Study Analysis of Tissue Plasminogen Activator. Nat Biotechnol 11, 349–357 (1993). https://doi.org/10.1038/nbt0393-349

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0393-349

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing